NMPA Adjusting Registration Application Payment Terms

NMPA issued a notice on the deferment of payment of registration review fees for drugs and medical device products (No. 81 of 2022) on September 29, 2022.

The main contents are as follows:

• Registration applicants who submit applications for registration of drugs and medical devices products and are accepted during the October 1 to December 31, 2022, the registration fee is suspended for one quarter from the date it is due, without late payment fees.
• Payment of review fees can be made by individuals using the payment code online transfer, but it needs to be handled in the bank that has opened the “non-tax payment” item.
• Recently, because of the Covid-19, the average acceptance review time will be increased by 2 working days on top of the original 5 working days.

For any questions of NMPA, please contact info@bradyknowsmedical.com.